We came across a bullish thesis on ADMA Biologics, Inc. on Archive Invest’s Substack by Felix. In this article, we will summarize the bulls’ thesis on ADMA. ADMA Biologics, Inc.'s share was trading at $17.80 as of August 22nd. ADMA’s trailing and forward P/E were 20.94 and 28.99 respectively according to Yahoo Finance.
Adma Biologics (ADMA) has delivered a remarkable financial turnaround, with 2024 standing out as a pivotal year. Gross profit has compounded at an impressive 34% CAGR from 2020 to 2024, reflecting strong topline expansion. Net income has moved from a loss of $75.5...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.